The man convicted of the Lockerbie bombing is living with his family in a luxury villa in Libya six months after he was released from jail on compassionate grounds because he had less than three months to live.

Abdelbaset Ali Mohmed al-Megrahi, who is suffering from terminal prostate cancer, no longer receives hospital treatment after ending the course of chemotherapy that he had been given after returning to his homeland last August...

...The latest disclosure will incense many of the relatives of those who died in the bomb blast in December 1988 when Pan Am Flight 103 exploded in mid air over Lockerbie, Scotland, killing 243 passengers, 16 crew and 11 people on the ground...

...The Sunday Telegraph revealed last September that the Libyan government had paid for the medical evidence which helped Megrahi, 57, to be released. The Libyans had encouraged doctors to say he had only three months to live.

The life expectancy of Megrahi was crucial because, under Scottish rules, prisoners can be freed on compassionate grounds only if they are considered to have this amount of time, or less, to live.

Kenny MacAskill, the Scottish Justice Secretary, ruled last August that Megrahi should be freed. Megrahi's release came after Libyan leaders warned that lucrative oil and trade deals with Britain would be cancelled if the bomber died in jail.

One leading prostate cancer specialist cast serious doubt yesterday on the wisdom of predicting that Megrahi had only three months to live - when a patient still had to undergo chemotherapy. Dr Chris Parker said it was extremely difficult to give an accurate prognosis for individual patients. "Studies show experts are very poor at trying to predict how long an individual patient will live for," he warned.

Megrahi received the chemotherapy drug Docetaxel - trade name Taxotere - shortly after returning to Libya.

Dr Parker, who is with the Institute of Cancer Research and the Royal Marsden Hospital, said: "The average prognosis for survival after Docetaxel would be 12 months....